Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 1, Pages 88-99
Publisher
Wiley
Online
2015-12-10
DOI
10.1002/cam4.566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
- (2015) Claudia Fiorini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray
- (2014) T Nitta et al. BRITISH JOURNAL OF CANCER
- A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma
- (2013) Amy L. Collins et al. ANNALS OF SURGICAL ONCOLOGY
- KRASandGNASmutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas
- (2013) Maylee Hsu et al. CANCER
- Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer
- (2013) N. Remmers et al. CLINICAL CANCER RESEARCH
- Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor
- (2013) Stephen J. Murphy et al. GASTROENTEROLOGY
- Ampullary cancer - a separate clinical entity?
- (2013) Iraklis Perysinakis et al. HISTOPATHOLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study
- (2013) Marianne Sinn et al. JOURNAL OF SURGICAL ONCOLOGY
- Targeting miR-21 for the Therapy of Pancreatic Cancer
- (2013) Flavie Sicard et al. MOLECULAR THERAPY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of MUC4 Mucin Is Observed Mainly in the Intestinal Type of Intraductal Papillary Mucinous Neoplasm of the Pancreas
- (2013) Iwao Kitazono et al. PANCREAS
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
- (2013) Masao Tanaka et al. PANCREATOLOGY
- Intraductal ultrasound substantiates diagnostics of bile duct strictures of uncertain etiology
- (2013) Tobias Meister WORLD JOURNAL OF GASTROENTEROLOGY
- Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy
- (2013) R Hill et al. Cell Death & Disease
- Differential Expression of Fascin, E-cadherin and Vimentin: Proteins Associated With Survival of Cholangiocarcinoma Patients
- (2012) Xianhai Mao et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
- (2012) Reyhan Bayrak et al. Diagnostic Pathology
- Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals
- (2012) Marcia Irene Canto et al. GASTROENTEROLOGY
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
- (2012) Mina Komuta et al. HEPATOLOGY
- S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
- (2012) Jia-Huei Tsai et al. HISTOPATHOLOGY
- The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma
- (2012) Jody E. Hooper et al. HUMAN PATHOLOGY
- Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules
- (2012) Chihiro Gandou et al. HUMAN PATHOLOGY
- Outcomes following resection of pancreatic cancer
- (2012) Elan R. Witkowski et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
- (2012) Viswam S. Nair et al. JNCI-Journal of the National Cancer Institute
- The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
- (2012) N Skrypek et al. ONCOGENE
- AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia
- (2012) A M Norris et al. ONCOGENE
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
- (2012) N. V. Chaika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
- (2012) Xing Yao et al. OncoTargets and Therapy
- Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity
- (2012) Vincenzo Cardinale World Journal of Gastrointestinal Oncology
- Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma
- (2011) Peter Neuhaus et al. ANNALS OF SURGICAL ONCOLOGY
- E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma
- (2011) K Araki et al. BRITISH JOURNAL OF CANCER
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues
- (2011) Michaela Aichler et al. JOURNAL OF PATHOLOGY
- Phase I/II Study of Hepatic Arterial Infusion Chemotherapy With Gemcitabine in Patients With Unresectable Intrahepatic Cholangiocarcinoma (JIVROSG-0301)
- (2010) Yoshitaka Inaba et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Embryology of the Biliary Tract
- (2010) Hisami Ando DIGESTIVE SURGERY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intraductal ultrasonography (IDUS) for the diagnosis of biliopancreatic diseases
- (2009) Naotaka Fujita et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma
- (2009) Yoshiaki Murakami et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
- (2008) O Nehls et al. BRITISH JOURNAL OF CANCER
- N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas
- (2008) Jean-François Mosnier et al. MODERN PATHOLOGY
- Combined Major Hepatectomy and Pancreaticoduodenectomy for Locally Advanced Biliary Carcinoma: Long-Term Results
- (2008) Toshifumi Wakai et al. WORLD JOURNAL OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now